Design Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 11.06 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 692.15M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ sys...